Skip to main content
OpenTrials

Clinical trial condition

Carcinoma

Explore clinical trials studying Carcinoma. Study availability and eligibility vary by location and protocol.

8,758 public trials 2,076 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma trial results

Active, Not Recruiting

A Pivotal Study of Safety and Effectiveness of NanoKnife IRE for Stage 3 Pancreatic Cancer

NCT03899636

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Ductal, +13 more
Locations
  • Miami Cancer Institute Miami, Florida, United States
  • University of South Florida/Tampa Tampa, Florida, United States
  • Northwest Community Healthcare Arlington Heights, Illinois, United States
  • Norton Healthcare Louisville, Kentucky, United States
View Trial Details
Active, Not Recruiting

A Study of Belzutifan (MK-6482) in Participants With Advanced Renal Cell Carcinoma (MK-6482-013)

NCT04489771

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +13 more
Locations
  • Georgetown University Medical Center ( Site 0002) Washington D.C., District of Columbia, United States
  • Univ of Miami- Sylvester Comprehensive Cancer Center ( Site 0023) Miami, Florida, United States
  • Norton Cancer Institute - St. Matthews ( Site 0025) Louisville, Kentucky, United States
  • Weinberg Cancer Institute at Franklin Square ( Site 0007) Baltimore, Maryland, United States
View all 48 locations
View Trial Details
Active, Not Recruiting

Study of Upfront Surgery Versus Neoadjuvant Chemotherapy in Patients With Advanced Ovarian Cancer (SUNNY)

NCT02859038

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +21 more
Locations
  • Sun Yet-Sen University Cancer Center Guangzhou, Guangdong, China
  • Zhongshan Hospital Fudan University Shanghai, Shanghai Municipality, China
  • Shanghai First Maternity and Infant Hospital Affiliated to Tongji University Shanghai, Shanghai Municipality, China
  • Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine Shanghai, Shanghai Municipality, China
View Trial Details
Active, Not Recruiting

A Study of XmAb20717 (Vudalimab)in Patients With Selected Advanced Gynecologic and Genitourinary Malignancies

NCT05032040

Conditions
Adenocarcinoma, Adenocarcinoma, Clear Cell, Adnexal Diseases, +34 more
Locations
  • Arizona Oncology Associates, PC - NAHOA Prescott, Arizona, United States
  • UCSD Moores Cancer Center La Jolla, California, United States
  • Valkyrie Clinical Trials Los Angeles, California, United States
  • UCLA Medical Center Los Angeles, California, United States
View all 17 locations
View Trial Details
Active, Not Recruiting

Volumetric Specimen Imager Device for the Intraoperative Imaging of Patients With Breast Carcinoma and Breast Ductal Carcinoma In Situ, The VIVID Study

NCT05545150

Conditions
Adenocarcinoma, Anatomic Stage 0 Breast Cancer AJCC v8, Bilateral Breast Carcinoma, +17 more
Locations
  • Northwestern University Chicago, Illinois, United States
  • The University of Kentucky Lexington, Kentucky, United States
  • Washington University in St. Louis St Louis, Missouri, United States
  • Cleveland Clinic Cleveland, Ohio, United States
View Trial Details
Active, Not Recruiting

Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced Cancers

NCT03212404

Conditions
Adenocarcinoma, Adenoma, Bronchial Neoplasms, +67 more
Locations
  • Research Site Wollongong, New South Wales, Australia
  • Research Site Benowa, Queensland, Australia
  • Research Site Buderim, Queensland, Australia
  • Research Site Greenslopes, Queensland, Australia
View all 48 locations
View Trial Details
Active, Not Recruiting

Safety and Efficacy Study of the Xoft® Axxent® eBx® IORT System®

NCT01644669

Conditions
Adenocarcinoma, Breast Carcinoma In Situ, Carcinoma, +8 more
Locations
  • University of Arizona Tucson, Arizona, United States
  • City of Hope Duarte, California, United States
  • Long Beach Memorial Medical Center Long Beach, California, United States
  • UCLA Los Angeles, California, United States
View all 24 locations
View Trial Details

Related conditions